Redox equilibrium (a balance between oxidative and reductive processes) governs many essential biological processes such as cellular signaling pathways, transcription factor activity, chromatin remodeling, protein modification, membrane integrity, and mitochondrial function. Most notably, an imbalance in the redox equilibrium toward an increase in reactive oxygen species (oxidative stress) is involved in the pathophysiology of multiple diseases including atherosclerosis, neurodegeneration, cancer, and heart failure ( Figure 1A) . Specifically, animal studies have demonstrated that heart failure can be induced by activation of enzymes that generate reactive oxygen species (ROS), such as NADPH oxidases and xanthine oxidase, as well as by the inhibition of enzymatic pathways counterbalancing its production (such as catalase and glutathione peroxidase, superoxide dismutase, and the thioredoxin/ thioredoxin reductase system) (Giordano, 2005) .
In surprising new work, Rajasekaran et al. now demonstrate that "reductive stress"-defined as an abnormal increase of reducing equivalents (in this case reduced glutathione [GSH] and NADPH)-contributes to the molecular pathogenesis of a specific type of cardiomyopathy triggered by protein aggregation ( Figure  1B ; Rajasekaran et al., 2007) . In a transgenic mouse model that mimics a human cardiomyopathy caused by a mutation in the gene encoding αB-crystallin (R120GCryAB), protein accumulation was associated with an increase in heat shock proteins and enhanced generation of the reducing equivalents NADPH and GSH. This occurred in parallel with increased activity of antioxidative enzymes such as catalase and glutathione peroxidase (Rajasekaran et al., 2007) . As expected, antioxidative cytoprotective pathways mitigated Oxidative stress due to the generation of reactive oxygen species has been implicated in many diseases. Rajasekaran et al. (2007) now make the surprising discovery that its counterpart "reductive stress," caused by an increase in reduced glutathione, contributes to cardiomyopathy triggered by protein aggregation. Rajasekaran et al. (2007) show that reductive stress, due to an increase in the production of reduced glutathione (GSH) and NADPH, contributes to the pathophysiology of a mouse model of human cardiomyopathy. These mice express the human mutant αB-crystallin protein (R120GCryAB), which leads to protein aggregation and cardiomyopathy. In this model, enhanced activity of glucose-6-phosphate dehydrogenase (G6PD) increases production of NADPH, the cofactor used in the conversion of glutathione disulfide (GSSG) to GSH. The mutant αB-crystallin protein also induces expression of heat shock proteins, in particular Hsp25, and of catalase and glutathione peroxidase, which decrease ROS levels. (C) Nitrosative stress, implicated in neurodegeneration, may also play a role in cardiac disease by promoting the accumulation of misfolded proteins. The transfer of a nitric oxide group to a critical cysteine thiol inactivates the molecular chaperone protein-disulfide isomerase. Nitrosative stress also targets a ubiquitin E3 ligase thereby impairing degradation of misfolded proteins by the proteasome.
increased stress in response to overexpression of the mutant crystallin protein. However, blocking the enzymatic activity of the rate-limiting enzyme in NADPH synthesis, glucose-6-phosphate dehydrogenase (G6PDH), to 20% of normal partially rescued the cardiomyopathy in crystallin mutant mice (although no longterm data are provided as to whether cardiac remodeling and survival are also fully restored). Thus, increased G6PDH activity enhanced the production of NADPH, a primary source of reducing equivalents, which appears to be necessary and sufficient for cardiomyopathy in this experimental animal model.
Although it is unclear why limiting NADPH accumulation rescued only some features of cardiomyopathy (such as increased expression of brain natriuretic peptide), the study clearly indicates that reductive stress may causally contribute to cardiomyopathy induced by protein aggregation. The balance between molecular pairs, such as the ratio of NADPH to NADP or that of glutathione to its oxidized form glutathione disulfide, regulates a number of transcription factors controlling genes that detoxify reactive molecules and/or maintain cellular homeostasis (Liu et al., 2005) . Moreover, NADPH is a cofactor for multiple enzymes including the NADPH oxidases and nitric oxide synthases. This raises the question of whether there is crosstalk between the pathways for reductive stress generated by G6PDH and the pathways for oxidative or nitrosative stress.
In neurodegenerative diseases, nitrosative stress has been implicated in misfolding and aggregation of proteins by affecting molecular chaperones and the ubiquitin proteasome system ( Figure 1C ; Hess et al., 2005; Nakamura and Lipton, 2007) . The transfer of a nitric oxide group to a critical cysteine thiol inactivates the molecular chaperone protein-disulfide isomerase leading to polyubiquitination and activation of the unfolded protein response (Uehara et al., 2006) . Nitrosative stress additionally targets an ubiquitin E3 ligase resulting in dysfunction of proteasomal degradation. The inactivation of these and others targets (for example, heat shock protein 90) contributes to abnormal protein accumulation and neuronal damage (Nakamura and Lipton, 2007) . Although the link between nitrosative stress and protein misfolding in heart failure has not yet been elucidated, it is likely that similar molecular mechanisms occur in the heart. An increase in G6PDH activity and the enhanced production of reducing equivalents might lead to an increase in nitrosative stress.
Interestingly, lowering G6PDH activity reduces the effects of loss of apolipoprotein E in mice, which has been used as a model of atherosclerosis. These mice exhibit less release of superoxide anion from vascular cells and have a decreased nitrotyrosine content, indicating that reduced G6PDH activity modulates the nitroso-redox balance (Matsui et al., 2006) . Although Rajasekaran et al. did not detect enhanced lipid peroxidation (a measure of increased ROS production) in their transgenic mice, the potential role of nitrosative stress has not yet been addressed. The inhibition of nitrosative stress by lowering G6PDH activity may contribute to the amelioration of cardiomyopathy in the αB-crystallin mutant mice. In addition, it would be interesting to determine whether the increased reducing environment translates into altered redox equilibrium within the endoplasmatic reticulum (ER). The ER participates in protein processing and folding and possesses a relatively oxidizing environment. Redox homeostasis is a prerequisite for ER activity (Gorlach et al., 2006) , and disturbing this balance might impair the physiological function of the ER, thereby further amplifying the accumulation of immature or denatured proteins.
Aberrant accumulation of proteins has been observed as a consequence of mutation or following the induction of oxidative stress. The demonstration that an increased reductive environment is causally involved in the cardiomyopathy induced by expression of a mutant protein provides a link between the pathophysiologies of protein aggregation diseases and oxidative/reductive stress. This leads to the question of whether dysregulation of oxidative/reductive/nitrosative stress is a general feature of diseases induced by protein misfolding. Clinically, the findings by Rajasekaran et al. may not only uncover new therapeutic targets to modulate cardiomyopathy induced by mutations in αB-crystallin but may also reconcile conflicting data from clinical trials assessing antioxidant therapies in patients with heart failure. Although some of the beneficial effects of drugs blocking the angiotensin II and the beta-adrenergic systems have been attributed, at least in part, to their ability to reduce ROS (Giordano, 2005) , the direct inhibition of ROS-producing enzymes (for example, xanthine oxidase) has produced rather disappointing results. Thus, the "reductionist" view elegantly presented in the Rajasekaran et al. study gives rise to a more comprehensive appreciation for approaches that might be used to counter the maladaptive mechanisms contributing to heart failure and other diseases.
